Cargando…
Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeutics
MicroRNAs (miRNAs) are short, noncoding RNAs functioning as regulators of the transcription of protein-coding genes in eukaryotes. During the last two decades, studies on miRNAs indicate that they have potential as diagnostic and prognostic biomarkers for a wide range of cancers. Research interest i...
Autor principal: | Gurwitz, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787538/ https://www.ncbi.nlm.nih.gov/pubmed/31636487 http://dx.doi.org/10.31887/DCNS.2019.21.2/dgurwitz |
Ejemplares similares
-
Future paths in psychopharmacology
por: Thibaut, Florence
Publicado: (2019) -
microRNAs as Novel Therapeutics in Cancer
por: Romano, Giulia, et al.
Publicado: (2021) -
Psychopharmacology of schizophrenia: The Future Looks Bleak
por: Andrade, Chittaranjan, et al.
Publicado: (2012) -
A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference
por: Lu, Yanjie, et al.
Publicado: (2009) -
MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
por: Aleshcheva, Ganna, et al.
Publicado: (2023)